Research
Awards Grant
A Multi-Center Study of a New Method of Sweat Testing: The CF Quantum Sweat Test
A Phase II Exploratory, Randomized, Placebo-Controlled Trial of Pomegranate Fruit Extract (PFE/PomX) in Subjects with Clinically Localized Prostate Cancer Undergoing Active Surveillance
A Phase IIB Randomized, Placebo-Controlled Trial of Pioglitazone for Oral Pre-Malignant Lesions: An Inter-Consortium Collaborative Study
A Randomized Double-Blind, Phase I Dose-Escalation Study of the Novel Retinoid 9cUAB30
A Randomized, Double-Blind, Phase I Dose-Escalation Study of the Novel Retinoid 9cUAB30
A Randomized, Double-Blind, Single-Dose and Multi-Dose Study of the Novel Retinoid, 9cUAB30 to Determine Pharmacokinetics and Safety
Alexander Disease: Cellular and Molecular Mechanisms
Assessing ADCC and Fc-Mediated Protection Against HIV
Caloric Restriction and Aging in Rhesus Macaques_R01 Competing _Colman Anderson
Cancer Prevention Agent Development Program: Early Phase Clinical Research
National Multi-Center Intrathecal Baclofen (ITB) Neuromuscular
Outliers - Extreme Long-term Survivors with Metastatic Breast Cancer
Phase IIB Randomized, Placebo-Controlled Trial of ACTOplus met® XR in Subjects with Stage I-IV Squamous Cell Carcinoma of the Oral Cavity or Oropharynx Prior to Definitive Treatment
Phase Ib 9cUAB30 in Early Stage Breast Cancer to Evaluate Biologic Effect
Reproductive Hormones in Skeletal Muscle Aging in Rhesus Monkeys
Schwann Cell Control of Blood-Nerve Barrier Structure and Function
Social Perception and Social Communication in Adults with Traumatic Brain Injury
Synstatin Therapy for Multiple Myeloma
UAB 1788: Pilot Study of Daily Exemestane in Women with Complex Alypical Hyperplasia of The Endometrium / Endometrial Intraepithelial Neoplasia or Grade 1 Endometrial Cancer (Fixed Price)
UAB 1788; Pilot Study of Daily Exemestane in Women with Complex Alypical Hyperplasia of The Endometrium / Endometrial Intraepithelial Neoplasia or Grade 1 Endometrial Cancer (Cost Reimbursable)
XUAB 1769: Phase lb 9cUAB30 In Early Stage Breast Cancer to Evaluate Biologic Effect (Cost Reimbursable)
